I was diagnosed in Nov.2002 with MDS Refractory Anemia. My presen (May 2005) diagnos is MDS with excess blast- Type 2 of 16% as per BMB slides (Morphology exam, Manual counting blast cells) and 9% blast as per Flow Cytometry test (Machine counting blasr cells). Any one has experience regarding which test (morphology or Flow Cytometry) is more reliable?
Dr. Greenberg at Stanford MDS Center gives more credibility to Morphology report. Dr. Paquette at UCLA gives more credibility to Flowcytometry report.
I am under treatment at Kaiser-Bellflower, CA. VIDAZA after 8 cycles of treatment did not help to reduce blast%. Now Dr. Greenberg of Stanford and Dr. Paquette of UCLA recommends to ZARNESTRA. Any one having experience of ZARNESTRA, please comment on side effects and effect on MDS